Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitroM G Cordingley, R L LaFemina, P L Callahan, et al.Journal of Translational Medicine|September 3, 2014
CD160 isoforms and regulation of CD4 and CD8 T-cell responsesMohamed El-Far, Charles Pellerin, Louise Pilote, et al.Journal of Virology|October 1, 1993
Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particlesS P Weinheimer, P J McCann, D R O'Boyle, et al.Antimicrobial Agents and Chemotherapy|August 8, 2012
The liver partition coefficient-corrected inhibitory quotient and the pharmacokinetic-pharmacodynamic relationship of directly acting anti-hepatitis C virus agents in humansJianmin Duan, Gordon Bolger, Michel Garneau, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 13, 2011
Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitorJianmin Duan, Chan-Loi Yong, Michel Garneau, et al.Journal of Medicinal Chemistry|August 2, 2012
Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)Pierre L Beaulieu, Michael Bös, Michael G Cordingley, et al.Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivativesC Yoakim, P R Bonneau, R Déziel, et al.Journal of Medicinal Chemistry|August 19, 2005
Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Christiane Yoakim, Pierre R Bonneau, et al.Journal of Medicinal Chemistry|November 14, 2014
Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infectionPierre L Beaulieu, Paul C Anderson, Richard Bethell, et al.Journal of Medicinal Chemistry|August 19, 2010
Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335)Montse Llinàs-Brunet, Murray D Bailey, Nathalie Goudreau, et al.Pageof 7